V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018043 | 260014487 | null | 89 | Curative (C) | 2017-09-03 | 2017-12-29 | VINCRISTINE | 02 | N | 260028311 | THALIDOMIDE |
| 260018044 | 260009398 | 1.67 | null | Disease modification (D) | 2018-05-16 | 2018-12-11 | ESHAP R | 02 | N | 260028315 | IVE |
| 260018045 | 260009404 | 1.62 | 57.7 | Curative (C) | 2017-09-19 | 2018-01-30 | DHAP | N | N | 260028348 | OBINUTUZUMAB |
| 260018046 | 260009406 | 1.81 | null | Disease modification (D) | 2018-04-24 | 2018-07-15 | GDP | N | N | 260028368 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018047 | 260009410 | 1.78 | 90 | Palliative (P) | 2016-09-28 | 2016-10-21 | IVE | Y | null | 260028377 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018048 | 260014494 | null | 90.7 | Palliative (P) | 2018-02-12 | 2018-02-12 | DHAP | 2 | N | 260028392 | BORTEZOMIB |
| 260018049 | 260009418 | 1.6 | 77.95 | null | 2017-10-07 | 2017-10-07 | Abiraterone | 02 | N | 260028398 | R-GEM-P |
| 260018050 | 260009419 | 1.57 | 53 | Disease modification (D) | null | 2018-05-25 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028399 | ESHAP |
| 260018051 | 260009423 | 1.65 | 67.5 | Neo-adjuvant (N) | 2016-03-10 | 2016-03-10 | ESHAP R | 2 | N | 260028405 | ESHAP R |
| 260018052 | 260009433 | 1.8 | 71.2 | Palliative (P) | 2016-01-19 | 2016-02-09 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260028436 | GEMCITABINE + TIP |
| 260018053 | 260009442 | null | 81.7 | Disease modification (D) | null | 2016-09-27 | IVA | N | N | 260028451 | BLEOMYCIN |
| 260018054 | 260009448 | 1.77 | 94.3 | Palliative (P) | null | 2017-07-22 | ESHAP | N | N | 260028460 | CHLORAMBUCIL + RITUXIMAB |
| 260018055 | 260016941 | 1.5 | null | Palliative (P) | null | 2016-07-25 | Pemetrexed | null | null | 260028467 | CYCLOPHOSPHAMIDE |
| 260018056 | 260009453 | 1.61 | 51.4 | null | 2016-12-12 | 2017-03-23 | Cyclophosphamide High Dose | null | null | 260028487 | AXITINIB |
| 260018057 | 260014509 | 1.63 | 105.5 | Disease modification (D) | 2015-11-18 | 2016-01-31 | METHOTREXATE | 02 | N | 260028489 | CVP |
| 260018058 | 260009463 | 1.63 | 59.6 | Palliative (P) | 2017-08-02 | 2017-08-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260028515 | CHOP |
| 260018059 | 260009471 | 1.74 | 86.2 | Palliative (P) | 2018-05-03 | 2018-06-03 | POMB | N | N | 260028530 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260018060 | 260014513 | 1.58 | 105 | null | 2017-11-29 | 2017-12-04 | CHOP - 21 days | N | N | 260028549 | CVP |
| 260018061 | 260009481 | 1.79 | 77.4 | Palliative (P) | 2013-08-03 | 2013-08-10 | Docetaxel + Trastuzumab (Maint) | N | N | 260028569 | CISPLATIN |
| 260018062 | 260014516 | null | 75.6 | Disease modification (D) | null | 2015-09-09 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260028572 | RMS 2005 TRIAL |
| 260018063 | 260009484 | 1.58 | 85.5 | Curative (C) | 2017-02-07 | 2017-02-20 | BLEOMYCIN + VINCRISTINE | 2 | N | 260028578 | CHOP |
| 260018064 | 260009494 | 1.8 | 115 | Curative (C) | 2015-03-16 | 2015-03-30 | METHOTREXATE + VINCRISTINE | N | N | 260028610 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018065 | 260009497 | 1.83 | null | Palliative (P) | 2016-05-10 | 2016-05-31 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 260028618 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018066 | 260009499 | 1.73 | 81.4 | Disease modification (D) | 2018-05-27 | 2018-06-08 | BLEOMYCIN | 02 | N | 260028633 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018067 | 260009502 | 1.72 | 83.3 | Curative (C) | null | 2017-12-02 | Gemcitabine + Oxaliplatin | N | null | 260028634 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260018068 | 260009504 | 1.86 | 77 | Disease modification (D) | 2016-11-05 | 2016-11-10 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260028637 | MAP |
| 260018069 | 260009506 | null | 51.4 | null | 2015-08-27 | 2015-09-02 | CYCLOPHOSPHAMIDE | 02 | N | 260028641 | BENDAMUSTINE + OBINUTUZUMAB |
| 260018070 | 260014524 | 1.71 | 78.3 | Palliative (P) | 2018-08-30 | 2018-08-31 | Gemcitabine + Oxaliplatin | 02 | N | 260028647 | CARBO + THIOTEPA + TOPOTECAN |
| 260018071 | 260009516 | null | null | Curative (C) | 2019-04-25 | 2019-07-05 | CISPLATIN + ETOPOSIDE + PACLITAXEL | null | null | 260028702 | POMB/ACE |
| 260018072 | 260014529 | 1.65 | 75 | null | 2017-11-30 | 2018-03-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260028717 | CARBOPLATIN + PACLITAXEL |
| 260018073 | 260009521 | 1.67 | 86 | Adjuvant (A) | 2015-10-07 | 2015-10-07 | BLEOMYCIN + VINCRISTINE | 02 | N | 260028731 | BLEOMYCIN + VINCRISTINE |
| 260018074 | 260009524 | null | 62 | Curative (C) | 2019-04-22 | 2019-05-27 | CARBOPLATIN + ETOPOSIDE | null | null | 260028735 | IVA |
| 260018075 | 260009528 | 1.58 | 89 | Curative (C) | 2018-07-19 | 2018-09-01 | BLEOMYCIN + VINCRISTINE | N | N | 260028757 | TRASTUZUMAB |
| 260018076 | 260014536 | 1.7 | 84.2 | null | 2016-04-30 | 2016-05-22 | IBRUTINIB | 02 | N | 260028763 | FEC |
| 260018077 | 260014538 | 1.7 | null | Palliative (P) | 2016-06-07 | 2016-08-18 | Cyclophosphamide High Dose | 02 | N | 260028772 | FEC |
| 260018078 | 260009537 | 1.75 | 72 | Adjuvant (A) | 2014-05-29 | 2014-06-01 | Methotrexate High Dose (3g/m2) | 02 | N | 260028790 | DOCETAXEL |
| 260018079 | 260014544 | 1.74 | 72 | Curative (C) | 2013-12-16 | 2013-12-17 | Pazopanib | 02 | N | 260028798 | BLEOMYCIN |
| 260018080 | 260009546 | 1.78 | 67.6 | Palliative (P) | 2014-07-16 | 2014-10-14 | TRASTUZUMAB | N | N | 260028814 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260018081 | 260009551 | 1.77 | 77 | Disease modification (D) | null | 2014-07-18 | R Chlorambucil | N | N | 260028818 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260018082 | 260009553 | null | null | Palliative (P) | 2016-01-20 | 2017-03-21 | Cytarabine HD + Methotrexate HD | N | N | 260028822 | ICE |
| 260018083 | 260009556 | null | null | Curative (C) | 2015-04-19 | 2015-05-24 | CVP | N | N | 260028854 | DOCETAXEL + TRASTUZUMAB |
| 260018084 | 260016969 | 1.56 | 79 | Adjuvant (A) | 2018-01-22 | 2018-01-23 | R-GEM-P | N | null | 260028878 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018085 | 260009565 | null | null | Disease modification (D) | 2018-11-15 | 2018-11-16 | Gemcitabine + Paclitaxel | Y | N | 260028881 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260018086 | 260009575 | 1.59 | 66 | Curative (C) | 2017-08-22 | 2017-12-13 | CHOP - 21 days | 02 | N | 260028923 | ICE |
| 260018087 | 260009578 | null | null | Palliative (P) | 2015-09-26 | 2015-09-28 | POMB/ACE | null | null | 260028934 | EP |
| 260018088 | 260016973 | 1.59 | 92.9 | Disease modification (D) | 2019-01-09 | 2019-01-10 | ICE | 2 | N | 260028943 | TRASTUZUMAB |
| 260018089 | 260009589 | 1.82 | 43.9 | Palliative (P) | 2013-06-23 | 2013-06-24 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260028975 | GEMCITABINE + TIP |
| 260018090 | 260009590 | 1.75 | 69.3 | Palliative (P) | 2017-01-23 | 2017-04-03 | Cyclophosphamide PO +Vinorelbine IV | null | null | 260028978 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018091 | 260009594 | null | null | Curative (C) | 2018-07-02 | 2018-07-29 | CHOP - 21 days | N | N | 260028993 | METHOTREXATE |
| 260018092 | 260009604 | 1.71 | 77.8 | Disease modification (D) | 2019-02-10 | 2019-02-27 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 260029017 | IGEV R |